Publication: The threat of antimalarial drug resistance
dc.contributor.author | Borimas Hanboonkunupakarn | en_US |
dc.contributor.author | White, Nicholas J. | en_US |
dc.contributor.other | Mahidol University. Faculty of Tropical Medicine. Department of Clinical Tropical Medicine | en_US |
dc.date.accessioned | 2017-08-09T06:00:31Z | |
dc.date.available | 2017-08-09T06:00:31Z | |
dc.date.created | 2017-08-09 | |
dc.date.issued | 2016 | |
dc.description.abstract | The battle between man and malaria has continued for thousands of years. Antimalarial drugs are essential weapons to fight the disease, but their efficacy is threatened by drug resistance which continues to emerge creating a major obstacle to malaria control and jeopardizing renewed hopes for elimination. As 2016 is the first year under WHO Global Technical Strategy for Malaria 2016–2030, it is a good time to ponder the progress of both sides and plan for the future. | en_US |
dc.identifier.citation | Tropical Diseases, Travel Medicine and Vaccines. Vol. 2, (2016), 10 | en_US |
dc.identifier.doi | 10.1186/s40794-016-0027-8 | |
dc.identifier.uri | https://repository.li.mahidol.ac.th/handle/20.500.14594/2751 | |
dc.language.iso | eng | en_US |
dc.rights | Mahidol University | en_US |
dc.rights.holder | BioMed | en_US |
dc.subject | Open Access article | en_US |
dc.subject | Antimalarial drug resistance | en_US |
dc.subject | Malaria | en_US |
dc.subject | Plasmodium falciparum | en_US |
dc.subject | Artemisinin | en_US |
dc.subject | Chloroquine | en_US |
dc.subject | Southeast Asia | en_US |
dc.title | The threat of antimalarial drug resistance | en_US |
dc.type | Review Article | en_US |
dspace.entity.type | Publication |